On April 14, 2017, the board of directors of ImmunoCellular Therapeutics, Ltd. appointed David Fractor as Chief Financial Officer of the Company, effective immediately. Mr. Fractor previously served as the Company's Treasurer and Chief Financial Officer on a part-time basis from April 2011 to March 2013 and as the Company's Vice President of Finance and Principal Accounting Officer on a part-time basis from March 2013 to April 2017.